These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36849124)

  • 1. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons.
    Fuyama K; Ogawa M; Mizusawa J; Kanemitsu Y; Fujita S; Kawahara T; Sakamaki K; Oba K
    Stat Med; 2023 May; 42(10):1606-1624. PubMed ID: 36849124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring.
    Péron J; Buyse M; Ozenne B; Roche L; Roy P
    Stat Methods Med Res; 2018 Apr; 27(4):1230-1239. PubMed ID: 27487842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
    Fukuda M; Sakamaki K; Oba K
    Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study.
    Giai J; Maucort-Boulch D; Ozenne B; Chiêm JC; Buyse M; Péron J
    Stat Med; 2021 Feb; 40(3):553-565. PubMed ID: 33140505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
    Cantagallo E; De Backer M; Kicinski M; Ozenne B; Collette L; Legrand C; Buyse M; Péron J
    Biom J; 2021 Feb; 63(2):272-288. PubMed ID: 32939818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correcting the bias of the net benefit estimator due to right-censored observations.
    Péron J; Idlhaj M; Maucort-Boulch D; Giai J; Roy P; Collette L; Buyse M; Ozenne B
    Biom J; 2021 Apr; 63(4):893-906. PubMed ID: 33615533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancer.
    Chamseddine AN; Oba K; Buyse M; Boku N; Bouché O; Satar T; Auperin A; Paoletti X
    Contemp Clin Trials; 2021 Jun; 105():106400. PubMed ID: 33866004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The asymptotic distribution of the Net Benefit estimator in presence of right-censoring.
    Ozenne B; Budtz-Jørgensen E; Péron J
    Stat Methods Med Res; 2021 Nov; 30(11):2399-2412. PubMed ID: 34633267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted Net Treatment Benefit in oncology.
    Piffoux M; Ozenne B; De Backer M; Buyse M; Chiem JC; Péron J
    J Clin Epidemiol; 2024 Jun; 170():111340. PubMed ID: 38570079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized pairwise comparisons for censored data: An overview.
    Deltuvaite-Thomas V; Verbeeck J; Burzykowski T; Buyse M; Tournigand C; Molenberghs G; Thas O
    Biom J; 2023 Feb; 65(2):e2100354. PubMed ID: 36127290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Net Benefit of a treatment should take the correlation between benefits and harms into account.
    Buyse M; Saad ED; Peron J; Chiem JC; De Backer M; Cantagallo E; Ciani O
    J Clin Epidemiol; 2021 Sep; 137():148-158. PubMed ID: 33774140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.
    Backer M; Sengar M; Mathews V; Salvaggio S; Deltuvaite-Thomas V; Chiêm JC; Saad ED; Buyse M
    Clin Trials; 2024 Apr; 21(2):180-188. PubMed ID: 37877379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trials.
    Cui Y; Dong G; Kuan PF; Huang B
    J Biopharm Stat; 2023 May; 33(3):272-288. PubMed ID: 36343174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of composite outcomes to assess risk-benefit in clinical trials.
    Shaw PA
    Clin Trials; 2018 Aug; 15(4):352-358. PubMed ID: 30021496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes.
    Dong G; Huang B; Verbeeck J; Cui Y; Song J; Gamalo-Siebers M; Wang D; Hoaglin DC; Seifu Y; Mütze T; Kolassa J
    Pharm Stat; 2023 Jan; 22(1):20-33. PubMed ID: 35757986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints.
    Deltuvaite-Thomas V; Burzykowski T
    Pharm Stat; 2022 Jan; 21(1):122-132. PubMed ID: 34346169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma.
    Péron J; Roy P; Conroy T; Desseigne F; Ychou M; Gourgou-Bourgade S; Stanbury T; Roche L; Ozenne B; Buyse M
    Oncotarget; 2016 Dec; 7(50):82953-82960. PubMed ID: 27765912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes.
    De Backer M; Legrand C; Péron J; Lambert A; Buyse M
    Pharm Stat; 2023 Mar; 22(2):284-299. PubMed ID: 36321470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trials.
    Giai J; Péron J; Roustit M; Cracowski JL; Roy P; Ozenne B; Buyse M; Maucort-Boulch D
    Stat Med; 2023 Jan; ():. PubMed ID: 36597195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.